Merrill Lynch


Merrill Lynch Offer Commentary On Bluebird Bio Inc (BLUE) Following Phase 1 Results In Relapsed/Refractory Multiple Myeloma

bluebird bio Inc (NASDAQ:BLUE) just announced Phase 1 results of bb2121, the BCMA CAR-T therapy, in patients with relapsed /refractory multiple myeloma that …

Merrill Lynch Values GoPro Inc (GPRO) From A Bearish Perspective Despite Rise In Black Friday Sales

GoPro Inc (NASDAQ:GPRO) released a Black Friday sales announcement disclosing an over 35% year-over-year rise in the action camera giant’s camera unit sales …

Analysts Offer Commentary on GoPro Inc (GPRO) and Fitbit Inc (FIT) Ahead of Rough Fourth-Quarter Waters

Rough tides are facing technology/consumer giants GoPro Inc (NASDAQ:GPRO) and Fitbit Inc (NYSE:FIT), with the former’s shares taking a hit after newly launched Karma …

Merrill Lynch Changes Ratings for Biotech Stocks ACADIA Pharmaceuticals Inc. (ACAD) and Rockwell Medical Inc (RMTI)

Tazeen Ahmad at Merrill Lynch, one of Wall Street’s best performing analysts, is out with newly bullish insights on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) while …

Merrill Lynch Runs for the Hills on GoPro Inc (GPRO) But Confident on NVIDIA Corporation (NVDA); Here’s Why

As earnings season finishes out, Merrill Lynch chimes in on GoPro Inc (NASDAQ:GPRO) and NVIDIA Corporation (NASDAQ:NVDA) after and ahead of their respective …

Notable Analyst Downgrades in Healthcare: Concordia International Corp (CXRX), Teva Pharmaceutical (TEVA)

Concordia International Corp Concordia International Corp (NASDAQ:CXRX) shares collapsed today, falling nearly 40%, after the Canadian generic-drug maker reported third-quarter results that were well below the Street’s …

The Biotech Talk: Analysts Mixed on Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD), and Pfizer Inc. (PFE)

Amid asset sale speculation and the cycle of earnings season, analysts from Mizuho, Maxim, and Merrill Lynch are offering insights into the key …

Merrill Lynch Remains Positive on NVIDIA Corporation (NVDA); Recognizes Multi-Billion Dollar Long-Term Growth Prospects

Merrill Lynch analyst Vivek Arya is out with a research report on NVIDIA Corporation (NASDAQ:NVDA) after hosting a lunch meeting with the company’s …

Investors are Underestimating Benefit of Bauxite Sales on Alcoa Inc (AA): Merrill Lynch

Alcoa Inc (NYSE:AA) is set to deliver third-quarter results tomorrow before market open, and Merrill Lynch analyst Timna Tanners is expecting bauxite sales …